Metformin: A Potential Drug for COVID-19
Metformin is an old drug, of plant origin, primarily used in the treatment of type 2 diabetes. The main mechanism of its action is mediated through adenosine monophosphate (AMP) kinase. Though the main action of metformin is to inhibit hepatic gluconeogenesis, it is also known to increase insulin se...
Saved in:
| Main Authors: | Anjali Devi Bettadapura Shankara Rao, Sujatha Puttalingaiah, Ananth B Koushik, Jadeppa Gowda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jaypee Brothers Medical Publisher
2024-04-01
|
| Series: | Indian Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin Combined with Aerobic Exercise Improved Liver Function in Rats with Non-alcoholic Fatty Liver Disease
by: HU Ge, QIN Fei, CAO Jianmin, JI Zhe, ZHOU Qiyun, ZHOU Haitao
Published: (2025-05-01) -
Hernandezine induces autophagic cell death in hepatocellular carcinoma cells via the AMPK/mTOR signaling pathway
by: WANG Jun, HU Gangfeng, GAO Weichen, WANG Lubing
Published: (2025-03-01) -
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01) -
Metformin attenuates alveolar bone destruction in mice with apical periodontitis and inhibits pro-inflammatory cytokine synthesis in lipopolysaccharide-stimulated RAW264.7 through the AMPK-mTOR-NF-κB pathway
by: Chunmei Ren, et al.
Published: (2025-07-01) -
A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19
by: Ruijuan Li, et al.
Published: (2025-02-01)